Back to Search
ALISON LEARY, PH.D.
PH.D.
Clinical Child & Adolescent Psychologist
NPI: 1265677157Individual
Specialties, Licenses & Credentials
Clinical Psychologist
Psychologist — Clinical
Code: 103TC0700X
PY60023173(WA)
Clinical Child & Adolescent PsychologistPrimary
Psychologist — Clinical Child & Adolescent
Code: 103TC2200X
PY60023173(WA)
Research & Publications (20)
An analysis of use of crowd medical services at an English football league club.
PMID 18627805·Int Emerg Nurs·2008
8-other
Observations of aggressive children during peer provocation and with a best friend.
PMID 15656743·Dev Psychol·2005
8-other
Coparenting, family-level processes, and peer outcomes: the moderating role of vagal tone.
PMID 15605627·Dev Psychopathol·2004
8-other
Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients.
PMID 19255333·J Clin Oncol·2009
6-review
24-hour variation in the reactivity of rate-pressure-product to everyday physical activity in patients attending a hypertension clinic.
PMID 19637053·Chronobiol Int·2009
8-other
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy.
PMID 19104814·Cancer Chemother Pharmacol·2009
3-trial
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.
PMID 18824559·Endocr Relat Cancer·2008
8-other
Enhancing endocrine response with novel targeted therapies: why have the clinical trials to date failed to deliver on the preclinical promise?
PMID 18072235·Cancer·2008
7-preclinical
The validation of a bioanalytical method for the determination of clopidogrel in human plasma.
PMID 17141580·J Chromatogr B Analyt Technol Biomed Life Sci·2007
8-other
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer.
PMID 17980056·Breast Cancer Res·2007
8-other
An open, randomized, controlled, phase II, single centre, two-period cross-over study to compare the quality of life and toxicity experienced on PEG interferon with interferon-alpha2b in patients with multiple myeloma maintained on a steady dose of interferon-alpha2b.
PMID 17693652·Ann Oncol·2007
3-trial
Small molecule signal transduction inhibitors for the treatment of solid tumors.
PMID 17661211·Cancer Invest·2007
6-review
Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients.
PMID 17160081·Br J Cancer·2006
8-other
Combination therapy with aromatase inhibitors: the next era of breast cancer treatment?
PMID 16926831·Br J Cancer·2006
6-review
Lapatinib: a novel EGFR/HER2 tyrosine kinase inhibitor for cancer.
PMID 16894399·Drugs Today (Barc)·2006
6-review
Is pathologic complete remission a useful measure of response to novel therapies in neoadjuvant trials?
PMID 16520798·Nat Clin Pract Oncol·2006
8-other
Reactivity of ambulatory blood pressure to physical activity varies with time of day.
PMID 16505205·Hypertension·2006
8-other
Pharmacokinetics and pharmacodynamics of intranasal insulin administered to patients with type 1 diabetes: a preliminary study.
PMID 16472054·Diabetes Technol Ther·2006
3-trial
5-Fluorouracil can cross brain-blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma.
PMID 16333678·Cancer Chemother Pharmacol·2006
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1218 3RD AVE, SUITE 500
SEATTLE, WA 98101 - Phone
- (206) 374-0109
Quick Facts
- NPI
- 1265677157
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile